Clinical Trial Update: Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock [NA]

View source ↗

Summary

A study evaluated personalized amikacin dosing guided by pharmacokinetic modeling software in patients with septic shock. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Shock, Septic | NA | Status: COMPLETED